Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Less than $10/month! View ALL results for your Stocks, ETFs and Funds Screeners with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Penumbra Inc (PEN)

Penumbra Inc (PEN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 13,725,886
  • Shares Outstanding, K 39,162
  • Annual Sales, $ 1,195 M
  • Annual Income, $ 14,010 K
  • EBIT $ 173 M
  • EBITDA $ 197 M
  • 60-Month Beta 0.71
  • Price/Sales 10.43
  • Price/Cash Flow 108.58
  • Price/Book 9.03

Options Overview Details

View History
  • Implied Volatility 13.56% (+0.45%)
  • Historical Volatility 45.26%
  • IV Percentile 1%
  • IV Rank 0.87%
  • IV High 65.18% on 04/08/25
  • IV Low 13.11% on 01/15/26
  • Expected Move (DTE 35) 10.03 (2.86%)
  • Put/Call Vol Ratio 0.13
  • Today's Volume 1,335
  • Volume Avg (30-Day) 547
  • Put/Call OI Ratio 0.40
  • Today's Open Interest 7,176
  • Open Int (30-Day) 3,350
  • Expected Range 340.75 to 360.81

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 19 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/25
See More
  • Average Estimate 1.12
  • Number of Estimates 8
  • High Estimate 1.24
  • Low Estimate 0.99
  • Prior Year 0.97
  • Growth Rate Est. (year over year) +15.46%

Price Performance

See More
Period Period Low Period High Performance
1-Month
290.00 +20.96%
on 01/13/26
352.15 -0.39%
on 01/15/26
+42.68 (+13.85%)
since 12/16/25
3-Month
221.26 +58.54%
on 11/03/25
352.15 -0.39%
on 01/15/26
+96.94 (+38.19%)
since 10/16/25
52-Week
221.26 +58.54%
on 11/03/25
352.15 -0.39%
on 01/15/26
+88.47 (+33.73%)
since 01/16/25

Most Recent Stories

More News
Penumbra Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Penumbra, Inc. - PEN

NEW YORK and NEW ORLEANS , Jan. 16, 2026 /PRNewswire/ -- Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC ("KSF") are investigating...

BSX : 88.07 (-2.18%)
PEN : 350.78 (+0.08%)
Stocks Boosted by Chip Demand Optimism

The S&P 500 Index ($SPX ) (SPY ) on Thursday closed up +0.26%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed up +0.60%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. March E-mini...

MSTR : 173.71 (+1.64%)
BLK : 1,163.17 (+0.56%)
AMAT : 327.01 (+2.49%)
MPC : 175.63 (-1.10%)
SNDK : 413.62 (+1.07%)
ADI : 300.25 (-0.61%)
MLTX : 16.76 (+2.51%)
$IUXX : 25,529.26 (-0.07%)
COIN : 241.15 (+0.78%)
ASML : 1,358.57 (+2.03%)
ZNH26 : 111-240s (-0.42%)
OXY : 42.70 (-1.09%)
Wall Street steadies as chip stocks bounce back and oil prices ease

Stocks steadied on Wall Street

BLK : 1,163.17 (+0.56%)
KLAC : 1,567.82 (+1.48%)
NVDA : 186.23 (-0.44%)
AMAT : 327.01 (+2.49%)
AVGO : 351.71 (+2.53%)
CVX : 166.26 (+0.06%)
BAC : 52.97 (+0.72%)
$SPX : 6,940.01 (-0.06%)
MS : 189.09 (-1.12%)
BSX : 88.07 (-2.18%)
GS : 962.00 (-1.42%)
$IUXX : 25,529.26 (-0.07%)
SHAREHOLDER ALERT: The M&A Class Action Firm Announces An Investigation of Penumbra, Inc. (NYSE: PEN)

NEW YORK , Jan. 15, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions...

PEN : 350.78 (+0.08%)
Why Penumbra (PEN) Stock Is Trading Up Today

Why Penumbra (PEN) Stock Is Trading Up Today

PEN : 350.78 (+0.08%)
Stocks Supported by Strength in Chip Makers and US Economic News

The S&P 500 Index ($SPX ) (SPY ) today is up +0.49%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.75%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.07%. March E-mini S&P futures (ESH26...

BLK : 1,163.17 (+0.56%)
MSTR : 173.71 (+1.64%)
AMAT : 327.01 (+2.49%)
MPC : 175.63 (-1.10%)
SNDK : 413.62 (+1.07%)
ADI : 300.25 (-0.61%)
MLTX : 16.76 (+2.51%)
$IUXX : 25,529.26 (-0.07%)
ASML : 1,358.57 (+2.03%)
ZNH26 : 111-240s (-0.42%)
OXY : 42.70 (-1.09%)
ESH26 : 6,976.75s (-0.07%)
Shareholder Alert: The Ademi Firm investigates whether Penumbra, Inc. is obtaining a Fair Price for its Public Shareholders

MILWAUKEE , Jan. 15, 2026 /PRNewswire/ -- Ademi LLP is investigating Penumbra (NYSE: PEN) for possible breaches of fiduciary duty and other violations of law in its recently announced transaction...

PEN : 350.78 (+0.08%)
Stock Indexes Rally on Chip Demand Optimism

The S&P 500 Index ($SPX ) (SPY ) today is up +0.55%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.20%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +1.00%. March E-mini S&P futures (ESH26...

BLK : 1,163.17 (+0.56%)
MSTR : 173.71 (+1.64%)
AMAT : 327.01 (+2.49%)
MPC : 175.63 (-1.10%)
AVGO : 351.71 (+2.53%)
SNDK : 413.62 (+1.07%)
MLTX : 16.76 (+2.51%)
$IUXX : 25,529.26 (-0.07%)
ZNH26 : 111-240s (-0.42%)
OXY : 42.70 (-1.09%)
ESH26 : 6,976.75s (-0.07%)
FANG : 151.28 (+0.30%)
PEN Stock Alert: Halper Sadeh LLC is Investigating Whether the Sale of Penumbra, Inc. is Fair to Shareholders

Shareholders should contact the firm as there may be limited time to enforce your rights.

PEN : 350.78 (+0.08%)
Boston Scientific announces agreement to acquire Penumbra, Inc.

Acquisition to expand Boston Scientific's cardiovascular portfolio and further address increasing prevalence of vascular diseases

BSX : 88.07 (-2.18%)
PEN : 350.78 (+0.08%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength is above 70%. The market is in overbought territory. Watch for a potential trend reversal.

See More Share

Business Summary

Penumbra, Inc. is an interventional therapies company. It designs, develops, manufactures and markets medical devices. The company's portfolio of products primarily addresses neuro and peripheral vascular medical conditions and clinical needs. Neuro products include Neurovascular Access, Neuron Access...

See More

Key Turning Points

3rd Resistance Point 355.15
2nd Resistance Point 353.61
1st Resistance Point 352.20
Last Price 350.78
1st Support Level 349.24
2nd Support Level 347.70
3rd Support Level 346.29

See More

52-Week High 352.15
Last Price 350.78
Fibonacci 61.8% 302.15
Fibonacci 50% 286.70
Fibonacci 38.2% 271.26
52-Week Low 221.26

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar